⌘K

Home/Filings/4/0001209191-16-139040

4//SEC Filing

FIVE PRIME THERAPEUTICS INC 4

Accession 0001209191-16-139040

CIK 0001175505operating

View on SEC.gov Company Profile

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 6:49 PM ET

Size

4.8 KB

Accession

0001209191-16-139040

Insider Transaction Report

Form 4

Period: 2016-08-25

FIVE PRIME THERAPEUTICS INCFPRX

Baker Kevin Paul

SVP, Development Sciences

Transactions

Award
Common Stock
2016-08-25+7,500→ 82,500 total

Footnotes (1)

[F1]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of September 1, 2017, 2018 and 2019.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

FIVE PRIME THERAPEUTICS INC

CIK 0001175505

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001175505

Filing Metadata

Form type: 4
Filed: Aug 28, 8:00 PM ET
Accepted: Aug 29, 6:49 PM ET
Size: 4.8 KB

View on SEC.gov